ScreenerHero

BIOBiofarm S.A.

BVB · RO · Healthcare · Drug Manufacturers - Specialty & Generic · biofarm.ro
1.360RON+0.37%Mkt Cap: 292.78M $P/E: 19.43

Biofarm S.A. manufactures pharmaceutical products. The company's products include cardiovascular, digestive and metabolic, genito-urinary, ophthalmological, endocrine, nervous system, osteo-muscular, respiratory and ENT,…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.19BUSDP/E 23.7
TAK
Takeda Pharmaceutical Co. Ltd.
$58.06BUSD
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.98BUSDP/E 20.4
TEVA
Teva Pharmaceutical Industries Limited
$43.51BUSDP/E 62.2
ZOE
Zoetis Inc.
$29.89BUSDP/E 12.7
ZTS
Zoetis Inc.
$32.12BUSDP/E 12.7
UTHR
United Therapeutics Corporation
$22.01BUSDP/E 18.4
VTRS
Viatris, Inc.
$18.75BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.34BUSDP/E 117.3
IPN
Ipsen S.A.
$14.67BUSDP/E 26.4
NBIX
Neurocrine Biosciences, Inc.
$15.51BUSDP/E 22.3
ELAN
Elanco Animal Health Incorporat
$11.98BUSD
RDY
Dr. Reddy's Laboratories Ltd
$10.15BUSDP/E 29.7
KRK
Krka, d. d.
$8.66BUSDP/E 19.0
ALKS
Alkermes plc
$8.11BUSDP/E 127.2
HIMS
Hims & Hers Health, Inc.
$7.88BUSD
LNTH
Lantheus Holdings Inc
$6.53BUSDP/E 23.9
AMRX
Amneal Pharmaceuticals, Inc. Class A
$6.24BUSDP/E 37.3
LQDA
Liquidia Corporation
$6.14BUSDP/E 49.0
KNSA
Kiniksa Pharmaceuticals, Ltd.
$6.08BUSDP/E 79.8

Key Statistics

Company
Market Cap292.78M $
Enterprise Value247.58M $
Revenue (TTM)64.29M $
Gross Profit59.62M $
Net Income (TTM)21.99M $
Revenue/Share0.0653 USD
Last Price1.360 RON
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees374
CountryRO
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINROBIOFACNOR9
Valuation
P/E (Trailing)19.43
P/E (Forward)—
PEG—
EV/EBITDA12.66
EV/Revenue3.85
P/S4.55
P/B3.39
EPS (TTM)0.07
EPS (Forward)—
52W Range
0.782081% of range1.495
52W High1.495 RON
52W Low0.7820 RON
Profitability
Gross Margin85.46%
Oper. Margin-23.94%
EBITDA Margin30.42%
Profit Margin31.51%
ROE18.35%
ROA15.80%
Growth
Revenue Growth-33.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF17.59M $
CapEx (TTM)3.20M $
FCF Margin52.16%
FCF Yield11.45%
Net Debt-45.20M $
Net Debt/EBITDA-2.31
Balance Sheet
Debt/Equity0.00
Current Ratio1.90
Quick Ratio1.53
Book Value/Sh0.4010 RON
Cash/Share0.2110 RON
Dividends
Fwd Div Rate0.0400 RON
Trail. Div Rate0.0420 RON
Div. Yield3.09%
5Y Avg Yield3.63%
Payout Ratio105.19%
Ex-Div DateJun 29, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.985.37M
Float476.14M
Insiders92.74%
Institutions0.00%
Technical
SMA 501.373 (-0.9%)
SMA 2001.197 (+13.7%)
Beta0.51
S&P 52W Chg19.18%
Avg Vol (30d)75.49K
Avg Vol (10d)55.89K
Technical Indicators
RSI (14)55.3
MACD-0.0051
MACD Signal-0.0107
MACD Hist.+0.0056
BB Upper1.354 RON
BB Middle1.335 RON
BB Lower1.316 RON
BB Width2.85%
ATR (14)0.0196 RON
Vol Ratio (20d)1.82x